Moderna’s Shift to Cancer Company Lifts Stock Up 177%
OMEGAZEPRIME News
This story was selected and curated by our editorial team in the Cancer category. Published on August 20, 2026 • Originally reported by Rebecca Robbins. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
This story was selected and curated by our editorial team in the Cancer category. Published on August 20, 2026 • Originally reported by Rebecca Robbins. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
OMEGAZEPRIME News — For more stories and analysis, visit omegazeprime.com